The subscription will be operated at a maximum price of RON35 per share and the final offering price will be set on December 16, the company said in a statement released Tuesday.
Whoever wants to buy shares can go to any Raiffeisen Bank unit or contact any eligible broker – a financial investment services company or a credit institution which signed with Raiffeisen Bank an engagement of compliance with the conditions stipulated in the prospectus of the offering.
Romania’s Financial Supervisory Authority (ASF) has approved Medlife’s listing on the Bucharest Stock Exchange. The offering will take place between December 6 – December 15 and will be brokered by Raiffeisen Bank and Wood&Company.